Our Cell Performance library of independent research demonstrates the effectiveness of BioLife Solutions' products.
Whether facing regulatory challenges against animal-derived fetal bovine serum, or the growing supply chain constraints of AB serum, with its specific donor population, many scientists are looking for new protein-based alternatives for culture media as a source of proteins, hormones, and cytokines to promotes cell growth in manufacturing.
Typically, the main consideration when evaluating a potential reagent change is the relative yield of viable cells throughout the process. The collection of research represented in this library has either been authored by BioLife scientists or by our customers, to evaluate the effectiveness of adding processed human platelet lysate to different cell therapies.